195 related articles for article (PubMed ID: 12895325)
1. [Losartan downregulates the expression of transforming growth factor beta type I and type II receptors in kidney of diabetic rat].
Guo ZX; Qiu MC
Zhonghua Nei Ke Za Zhi; 2003 Jun; 42(6):403-8. PubMed ID: 12895325
[TBL] [Abstract][Full Text] [Related]
2. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
Volpini RA; da Silva CG; Costa RS; Coimbra TM
Diabetes Metab Res Rev; 2003; 19(1):43-51. PubMed ID: 12592643
[TBL] [Abstract][Full Text] [Related]
3. [Expression of type I transforming growth factor beta receptor in renal cortex in streptozotocin-induced diabetic rats and the regulation of benazepril].
Wu Y; Lin S
Zhonghua Nei Ke Za Zhi; 1999 Jan; 38(1):9-13. PubMed ID: 11798618
[TBL] [Abstract][Full Text] [Related]
4. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
Zuo Y; Gu Y; Ma J; Lin S
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):239-43. PubMed ID: 11953170
[TBL] [Abstract][Full Text] [Related]
5. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
[TBL] [Abstract][Full Text] [Related]
6. [Renal protective effect of valsartan in diabetic rats].
Wen H; Lin S
Zhonghua Nei Ke Za Zhi; 1999 Mar; 38(3):157-60. PubMed ID: 11798641
[TBL] [Abstract][Full Text] [Related]
7. Effects of diabetes and hypertension on glomerular transforming growth factor-beta receptor expression.
Kang MJ; Ingram A; Ly H; Thai K; Scholey JW
Kidney Int; 2000 Oct; 58(4):1677-85. PubMed ID: 11012901
[TBL] [Abstract][Full Text] [Related]
8. [Effects of losartan on the levels of angiotensin II and its type-1 receptor in diabetic rat kidney].
Wu W; Ding HL; Chen LH; Fu ZZ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1742-4. PubMed ID: 17259110
[TBL] [Abstract][Full Text] [Related]
9. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
[TBL] [Abstract][Full Text] [Related]
10. [The effect of losartan on glomerular sclerosis in rats with diabetic nephropathy].
Xu JY; Tao LJ; Wang L; Ning WB; Liu JS
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 33(9):836-40. PubMed ID: 18812664
[TBL] [Abstract][Full Text] [Related]
11. Effect of catalpol on diabetic nephropathy in rats.
Dong Z; Chen CX
Phytomedicine; 2013 Aug; 20(11):1023-9. PubMed ID: 23746755
[TBL] [Abstract][Full Text] [Related]
12. [Effects of losartan on MT3-MMP and TIMP2 mRNA expressions in diabetic rat kidney].
Wan X; Huang HH; Li JG
Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1391-4. PubMed ID: 15604066
[TBL] [Abstract][Full Text] [Related]
13. Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetes.
Qin J; Zhang Z; Liu J; Sun L; Hu L; Cooper ME; Cao Z
Kidney Int; 2003 Aug; 64(2):565-71. PubMed ID: 12846751
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of blocking renin-angiotensin system on the progression of renal injury in glomerulosclerosis.
Ji Z; Huang C; Liang C; Chen B; Chen S; Sun W
Cell Mol Immunol; 2005 Apr; 2(2):150-4. PubMed ID: 16191423
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats.
Yuan J; Jia R; Bao Y
J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):118-26. PubMed ID: 17907099
[TBL] [Abstract][Full Text] [Related]
16. The renal expression of transforming growth factor-beta isoforms and their receptors in acute and chronic experimental diabetes in rats.
Hill C; Flyvbjerg A; Grønbaek H; Petrik J; Hill DJ; Thomas CR; Sheppard MC; Logan A
Endocrinology; 2000 Mar; 141(3):1196-208. PubMed ID: 10698197
[TBL] [Abstract][Full Text] [Related]
17. [Protective effect of angiotensin II receptor blockage on rats with experimental diabetes nephropathy in early stage].
Yang L; Fan J; Mi X; Liu X; Xu G
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):317-9. PubMed ID: 12947726
[TBL] [Abstract][Full Text] [Related]
18. [Effect of losartan on expression of Janus kinase 2 and signal transducer and activator of transcription 3 in glomeruli of diabetic rats].
Shi YH; Duan HJ; He N; Wang LH; Liu QJ; Gao F
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Nov; 17(11):662-6. PubMed ID: 16297319
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-β/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats.
Chen KH; Hung CC; Hsu HH; Jing YH; Yang CW; Chen JK
Chem Biol Interact; 2011 Mar; 190(1):45-53. PubMed ID: 21300041
[TBL] [Abstract][Full Text] [Related]
20. [Effects of simvastatin on TGF-beta system of diabetic rat kidneys].
Chen ZX; Lei MX; Zhu LF; Zhang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):593-6. PubMed ID: 16320597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
